Company intelligence / Profile preview

Langzhi Pharmaceutical

Chengdu, Sichuan, Chinancbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

Langzhi's digital care business offers commercialized solutions for real-time remote patient monitoring with features like contactless measurement of vital signs, abnormality alerts via app/platforms, sleep/emotional stress analysis, heart health analytics, mite removal technology using graphene heating, and far-infrared therapy. The company has established a global presence with operations in Germany, UK, Japan, France among others[9].

No clinical results or pipeline details are available for any pharmaceutical drug development programs.

Therapeutic areas: Cardiovascular
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Langzhi Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Langzhi Pharmaceutical.

Explore the full profile